Refractory Autoimmune Diseases

Immunology·MeSH: Autoimmune Diseases

6 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Phase 1(6)

Drug	Company
bms-986515	Juno Therapeutics, Inc. (JUNO)
fludarabine	Juno Therapeutics, Inc. (JUNO)
LCAR-AIO T cells	Legend Biotech Corp (LEGN)
LUCAR-DKS1 NK cells	Legend Biotech Corp (LEGN)
LUCAR-G79 T cells	Legend Biotech Corp (LEGN)
tocilizumab	Juno Therapeutics, Inc. (JUNO)

Compare drugs

bms-986515 vs fludarabine bms-986515 vs LCAR-AIO T cells bms-986515 vs LUCAR-DKS1 NK cells

Frequently asked questions

How many drugs are in development for Refractory Autoimmune Diseases?

BioSniper tracks 6 drugs in development for Refractory Autoimmune Diseases across 2 companies.

How many clinical trials target Refractory Autoimmune Diseases?

There are 1 clinical trial targeting Refractory Autoimmune Diseases tracked by BioSniper.

Deep-dive into Refractory Autoimmune Diseases

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Refractory Autoimmune Diseases — Drugs in Development & Clinical Trials | BioSniper